PAVmed Inc (PAVM) USD0.001
Sell:$0.76Buy:$0.79
$0.02
(2.54%)
- This stock can be held in a
Stocks and Shares ISA$0.02
(2.54%)$0.02
(2.54%)Company Information
About this company
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.
Key people
Key facts
- EPICPAVM
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS70387R4039
- Market cap$13.72m
- Employees39
- Shares in issue17.37m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.